In the landscape of molecular biology and immunological research, the OTII OVA peptide stands out as a foundational tool for investigators. As someone who has spent time analyzing various biochemical reagents, I have found that understanding the specific nuances of these sequences is essential for anyone focusing on T-cell receptor (TCR) transgenic models.
The Foundation: Ovalbumin and the OTII Model
At its core, Ovalbumin (OVA) is a protein derived from eg Sep 14, 2014 — I want to activate CD4+ T cells (from OTII mice) in the presence of IL-27 using OVA peptide. I would like to use a suspension of whole splenocytes to g whites, frequently utilized as a model antigen. When discussing the OTII system, we are looking at a specific transgenic mouse model where CD4+ T cells express a TCR that is highly specific for the ovalbumin residue 323-339 peptides. This sequence, often referred to as the OVA 323-339 peptide, is a critical component for those studying MHC class II-restricted responses.
From my experience, when sourcing these materials, it is vital to distinguish between the various epitope lengths. While researchers often use the full OVA 323-339 (sequence: ISQAVHAAHAEINEAGR), there are also shorter variants like the OVA (329-337), which is frequently utilized to achieve precise binding in the context of I-Ab MHC class II molecules.
Differentiating Peptide Specificities
One common point of confusion for those new to this field is the distinction between class I and class II restricted epitopes:
* OVA 257-264 peptides (SIINFEKL): These are the classic class I (Kb)-restricted peptide epitope of OVA. They are essential for studies involving CD8+ T cells and the OT-I model.
* OVA 323-339: This is the primary H-2b-restricted OVA MHC class II epitope. It is the gold standard for a 004194 - OT-II Strain Details ctivating CD4+ T cells derived from OTII mice.
If you are looking for OVA wt peptide 323-339, ensure that your supplier provides high-purity, HPLC-verified material. The purity of these peptides directly influences the consistency of activation assays, especially when co-culturing with splenocytes or dendritic by B Akkaya · 2019 · Cited by 362 — b-c) CD11c-YFP DCs were loaded with 3 μM OVA(323–339) peptide and co-cultured with OT-II Tactivated (CD45.1+) or OT-II iTregs (CD45.1+) for 3 h. cells.
Experimental Insights and Observations
When wor This sequence is OVA (ovalbumin) peptide residues 257 to 280, also known as OT-II (OVA-specific T-cell receptor) peptide, the core H2b-restricted class II MHC king with OTII cells, the activation threshold is a key variable. I have observed that us Gas plasma technology augments Ovalbumin immunogenicity and OT-II T cell activation conferring tumor protection in mice. ing the OVA 323-339 peptide allows for robust proliferation of these transgenic T cells. For those exploring the OVA (ovalbumin) peptide residues 257 to 280 or other truncated versions, remember that binding affinity can shift depending on the MHC context.
The OVA peptide mainly exists in egg white, but the synthetic versions used in labs—such as the Ovalbumin protein Ova (323-339)—are synthesized to ensure that the concentration and purity are controlled. Whether you are using BP-OVA (biopolymer-conjugated) or soluble OVA peptides specific for OT-I and OT-II, the goal remains the same: maintaining a stable, reproducible interaction between the antigen and the TCR.
Best Practices for Selection
1. Verify the Sequence: Always confirm the amino acid sequence provided by the manufacturer. For example, the OVA 323-339 peptide is consistently cited as ISQAVHAAHAEINEAGR.
2. MHC Context: Ensure that your experimental model aligns with the restriction of the peptide (e.g., ensuring you are using the correct class I (Kb)-restricted peptide epitope of OVA if your study focus is on OT-I).
3. Storage: These reagents are sensitive. I recommend aliquoting the OVA peptide upon arrival and storing it at -20°C or lower to prevent degradation.
By focusing on high-quality reagents and understanding the specif T regulatory cells mediate specific suppression by depleting ic MHC-peptide interactions, researchers can achieve more reliable data in In vivo assembly of epitope-coated biopolymer particles their immunological studies. The OTII model remains a powerful, highly specific system for observing T-cell behavior, provided the correct ovalbumin peptide is utilized in the experimental design.